Search Results 81-90 of 14448 for FMT and Ulcerative Colitis

  1. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  2. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.

  3. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · Male or female participants ≥ 18 and ≤ 75 years of age at Baseline. · Diagnosis of Ulcerative Colitis (UC) for 90 days or greater ...

  4. Mayo Clinic Minute: Can diet help with inflammatory bowel disease?

    IBD is a broad term for chronic inflammation of your digestive tract. Two types are Crohn's disease and ulcerative colitis. “Ulcerative colitis really tends ...

  5. Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis - Mayo Clinic

    Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.

  6. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  7. A Study to Assess Effectiveness and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis. Participation ...

  8. Study Of GS-1427 In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    The goal of this study is to learn if GS-1427 is effective in treating participants with moderate to severe ulcerative colitis. The study will compare ...

  9. A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis · Overview · Participation ...

  10. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.